Evidence map›Paper›PMID 27148550›Full record

ArticleBioMed research international2016

Epidemiology of Endometriosis in France: A Large, Nation-Wide Study Based on Hospital Discharge Data.

Peter von Theobald, Jonathan Cottenet, Silvia Iacobelli, Catherine Quantin

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Endometriosis and adverse pregnancy outcomes: A case-control study.International journal of reproductive biomedicine · 2024
    Article
  8. Article
  9. Article
  10. The impact of endometriosis on work ability in young Australian women.The Australian & New Zealand journal of obstetrics & gynaecology · 2023
    Article
  11. Article
  12. Article
  13. Curcumol Attenuates Endometriosis by Inhibiting the JAK2/STAT3 Signaling Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  14. Review
  15. Epidemiology of Endometriosis in Spain and Its Autonomous Communities: A Large, Nationwide Study.International journal of environmental research and public health · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Peter von TheobaldCentre d'Etudes Périnatales de l'Océan Indien (EA 7388), CHU de la Réunion, Site Sud, 97448 Saint-Pierre, France; Department of Gynecology and Obstetrics, Hospital Felix Guyon, CHU de la Reunion, Site Nord, 9740 Saint Denis, France.
Jonathan CottenetCHRU Dijon, Service de Biostatistique et d'Informatique Médicale (DIM) and Université de Bourgogne Franche-Comté, 21000 Dijon, France.
Silvia IacobelliCentre d'Etudes Périnatales de l'Océan Indien (EA 7388), CHU de la Réunion, Site Sud, 97448 Saint-Pierre, France; Néonatologie, Réanimation Néonatale et Pédiatrique, CHU de la Réunion, Site Sud, 97448 Saint-Pierre, France.
Catherine QuantinCHRU Dijon, Service de Biostatistique et d'Informatique Médicale (DIM) and Université de Bourgogne Franche-Comté, 21000 Dijon, France; INSERM, CIC 1432 and Dijon University Hospital, Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, 21000 Dijon, France; INSERM UMR 1181 "Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases" (B2PHI), University Bourgogne Franche-Comté, 21000 Dijon, France.
Écologie Marine Tropicale des Océans Pacifique et Indien · REMaison des Sciences sociales et des Humanités de Dijon · FRUniversité de Bourgogne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to assess the prevalence of hospitalization for endometriosis in the general population in France and in each French region and to describe temporal trends, rehospitalization rates, and prevalence of the different types of endometriosis. The analyses were carried out on French hospital discharge data and covered the period 2008-2012 and a population of 14,239,197 women of childbearing age. In this population, the prevalence of hospitalization for endometriosis was 0.9%, ranging from 0.4% to 1.6% between regions. Endometriosis affected 1.5% of hospitalized women of childbearing age, ranging from 1.0% to 2.4% between regions. The number of patients hospitalized for endometriosis significantly increased over the study period (p < 0.01). Of these, 4.2% were rehospitalized at least once at one year: ranging from 2.7% to 6.3% between regions. The cumulative rehospitalization rate at 3 years was 6.9%. The types of endometriosis according to the procedures performed were as follows: ovarian (40-50%), peritoneal (20-30%), intestinal (10-20%), and ureteral or bladder (<10%), with significant differences between regions. This is the first detailed epidemiological study of endometriosis in France. Further studies are needed to assess the reasons for the increasing prevalence of endometriosis and for the significant differences in regional prevalence of this disease.

Indexed as

Patient DischargeAdolescentAdultData CollectionEndometriosisFemaleFranceGeographyHospitalizationHumansMiddle AgedModels, StatisticalPrevalenceRisk FactorsTime FactorsYoung Adult

Identifiers

PMID27148550
PMCPMC4842348
OpenAlexW2320970686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.